Profile | GDS5420 / 208800_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 404.23 | 64 |
GSM1296119 | B_lesional_pre-dose | 1122.98 | 81 |
GSM1296076 | C_lesional_pre-dose | 1051.15 | 80 |
GSM1296092 | D_lesional_pre-dose | 814.52 | 76 |
GSM1296103 | E_lesional_pre-dose | 531.69 | 69 |
GSM1296078 | F_lesional_pre-dose | 1018.11 | 79 |
GSM1296107 | G_lesional_pre-dose | 901.26 | 78 |
GSM1296109 | H_lesional_pre-dose | 862.85 | 77 |
GSM1296080 | I_lesional_pre-dose | 282.15 | 59 |
GSM1296090 | J_lesional_pre-dose | 864.79 | 77 |
GSM1296074 | K_lesional_pre-dose | 940.06 | 78 |
GSM1296111 | L_lesional_pre-dose | 1411.1 | 85 |
GSM1296099 | M_lesional_pre-dose | 635.33 | 71 |
GSM1296086 | O_lesional_pre-dose | 807.37 | 76 |
GSM1296117 | P_lesional_pre-dose | 1563.2 | 86 |
GSM1296113 | Q_lesional_pre-dose | 956.17 | 79 |
GSM1296096 | R_lesional_pre-dose | 674.46 | 73 |
GSM1296105 | S_lesional_pre-dose | 341.48 | 61 |
GSM1296098 | T_lesional_pre-dose | 333.64 | 61 |
GSM1296101 | U_lesional_pre-dose | 255.3 | 56 |
GSM1296121 | V_lesional_pre-dose | 903.14 | 78 |
GSM1296088 | W_lesional_pre-dose | 554.62 | 69 |
GSM1296082 | X_lesional_pre-dose | 849.07 | 77 |
GSM1296115 | Y_lesional_pre-dose | 1410 | 85 |
GSM1296084 | Z_lesional_pre-dose | 374.03 | 63 |
GSM1296072 | B_lesional_day8 | 723.89 | 74 |
GSM1296069 | L_lesional_day8 | 1197.54 | 82 |
GSM1296071 | P_lesional_day8 | 845.73 | 77 |
GSM1296070 | Y_lesional_day8 | 992.77 | 79 |
GSM1296073 | V_lesional_day8 | 1158.91 | 81 |
GSM1296034 | A_lesional_day15 | 213.29 | 52 |
GSM1296041 | G_lesional_day15 | 1297.33 | 83 |
GSM1296035 | R_lesional_day15 | 564.37 | 69 |
GSM1296038 | U_lesional_day15 | 510.46 | 68 |
GSM1296047 | B_lesional_day15 | 704.08 | 73 |
GSM1296039 | E_lesional_day15 | 798.57 | 76 |
GSM1296042 | H_lesional_day15 | 1022.38 | 80 |
GSM1296043 | L_lesional_day15 | 902.68 | 78 |
GSM1296037 | M_lesional_day15 | 371.59 | 62 |
GSM1296046 | P_lesional_day15 | 889.4 | 77 |
GSM1296044 | Q_lesional_day15 | 884.47 | 77 |
GSM1296045 | Y_lesional_day15 | 899.32 | 78 |
GSM1296025 | C_lesional_day15 | 311.79 | 60 |
GSM1296033 | D_lesional_day15 | 481.54 | 67 |
GSM1296027 | I_lesional_day15 | 438.02 | 66 |
GSM1296032 | J_lesional_day15 | 400.57 | 64 |
GSM1296024 | K_lesional_day15 | 191.23 | 52 |
GSM1296031 | W_lesional_day15 | 337.42 | 60 |
GSM1296028 | X_lesional_day15 | 388.13 | 63 |
GSM1296029 | Z_lesional_day15 | 354.31 | 62 |
GSM1296026 | F_lesional_day15 | 550.94 | 70 |
GSM1296030 | O_lesional_day15 | 569.85 | 70 |
GSM1296040 | S_lesional_day15 | 432.72 | 65 |
GSM1296036 | T_lesional_day15 | 381.83 | 62 |
GSM1296048 | V_lesional_day15 | 838.1 | 76 |
GSM1296059 | A_lesional_day43 | 632.16 | 72 |
GSM1296066 | G_lesional_day43 | 998.45 | 80 |
GSM1296060 | R_lesional_day43 | 610.04 | 71 |
GSM1296063 | U_lesional_day43 | 800.56 | 76 |
GSM1296064 | E_lesional_day43 | 1038.92 | 80 |
GSM1296067 | H_lesional_day43 | 546.69 | 69 |
GSM1296062 | M_lesional_day43 | 402.89 | 63 |
GSM1296068 | Q_lesional_day43 | 694.78 | 73 |
GSM1296050 | C_lesional_day43 | 650.37 | 72 |
GSM1296057 | D_lesional_day43 | 432.57 | 65 |
GSM1296052 | I_lesional_day43 | 402.55 | 64 |
GSM1296054 | J_lesional_day43 | 375.51 | 62 |
GSM1296049 | K_lesional_day43 | 178.19 | 51 |
GSM1296055 | W_lesional_day43 | 420.8 | 64 |
GSM1296053 | X_lesional_day43 | 244.89 | 55 |
GSM1296058 | Z_lesional_day43 | 316.53 | 60 |
GSM1296051 | F_lesional_day43 | 672.93 | 73 |
GSM1296056 | O_lesional_day43 | 760.48 | 75 |
GSM1296065 | S_lesional_day43 | 830.84 | 76 |
GSM1296061 | T_lesional_day43 | 383.44 | 62 |
GSM1296095 | A_non-lesional_pre-dose | 655.73 | 72 |
GSM1296120 | B_non-lesional_pre-dose | 798.44 | 76 |
GSM1296077 | C_non-lesional_pre-dose | 573.9 | 70 |
GSM1296093 | D_non-lesional_pre-dose | 88.08 | 38 |
GSM1296104 | E_non-lesional_pre-dose | 724.6 | 74 |
GSM1296079 | F_non-lesional_pre-dose | 419.11 | 65 |
GSM1296108 | G_non-lesional_pre-dose | 700.38 | 73 |
GSM1296110 | H_non-lesional_pre-dose | 616.39 | 71 |
GSM1296081 | I_non-lesional_pre-dose | 157.88 | 50 |
GSM1296091 | J_non-lesional_pre-dose | 620.97 | 71 |
GSM1296075 | K_non-lesional_pre-dose | 806.13 | 76 |
GSM1296112 | L_non-lesional_pre-dose | 726.64 | 74 |
GSM1296100 | M_non-lesional_pre-dose | 372.72 | 62 |
GSM1296087 | O_non-lesional_pre-dose | 479.45 | 67 |
GSM1296118 | P_non-lesional_pre-dose | 741.01 | 74 |
GSM1296114 | Q_non-lesional_pre-dose | 771.77 | 75 |
GSM1296097 | R_non-lesional_pre-dose | 516.75 | 68 |
GSM1296106 | S_non-lesional_pre-dose | 466.65 | 66 |
GSM1296102 | U_non-lesional_pre-dose | 297.26 | 58 |
GSM1296122 | V_non-lesional_pre-dose | 544.45 | 69 |
GSM1296089 | W_non-lesional_pre-dose | 393.76 | 63 |
GSM1296083 | X_non-lesional_pre-dose | 190.1 | 51 |
GSM1296116 | Y_non-lesional_pre-dose | 861.15 | 77 |
GSM1296085 | Z_non-lesional_pre-dose | 368.32 | 62 |